Sign inJoin waitlistJoin the waitlist

Manish A Shah

Director, Gastrointestinal Oncology Program · Weill Cornell Medicine

Credentials: · · · · ·

History

Gastrointestinal Oncology Program · Weill Cornell Medicine
Present
Solid Tumor Service Division · NewYork-Presbyterian
Present
Center for Advanced Digestive Disease · NewYork-Presbyterian
Present

2000–2001
Memorial Sloan-Kettering Cancer Center
1999–2001
Joan and Sanford I. Weill Medical College
1999–2001
Duke University Medical Center
1998–1999
Duke University Medical Center
Until 1997
Harvard Medical School / Health Sciences and Tech
1991–1996
Johns Hopkins University
1987–1991

Research

Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer: Phase 2 Clinical KEYNOTE-059 Trial
JAMA Oncology · 2018 · 1,507 citations
Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study
The Lancet · 2021 · 1,369 citations
Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: a randomized, double-blind, placebo-controlled phase III study
Journal of Clinical Oncology · 2011 · 932 citations

DK
David Kelsen
43 papers
LT
Laura Tang
23 papers
DC
Daniel Coit
22 papers
DI
David Ilson
17 papers
Gary Schwartz
17 papers
EO
Eileen O'Reilly
16 papers
MB
Murray Brennan
16 papers
Peter Enzinger
16 papers
Allyson Ocean
15 papers
VS
Vivian Strong
15 papers
YJ
Yelena Janjigian
13 papers
Jaffer Ajani
11 papers